concizumab

Italy

Drugs containing this active substance

  • ALHEMO

    It is used to prevent or reduce the frequency of bleeding in adults and adolescents (from 12 years of age and older) with hemophilia A (with inhibitors or severe without inhibitors) or hemophilia B (with inhibitors or moderate/severe without inhibitors).

    Form: solution for injection, in pre-filled pen

    Active substance Dosage
    concizumab -

    ATC: B02BX10

    Manufacturer: NOVO NORDISK A/S